These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1942320)

  • 1. Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-fluoro-D-glucose: pilot animal and human studies.
    Wahl RL; Harney J; Hutchins G; Grossman HB
    J Urol; 1991 Dec; 146(6):1470-4. PubMed ID: 1942320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography.
    Harney JV; Wahl RL; Liebert M; Kuhl DE; Hutchins GD; Wedemeyer G; Grossman HB
    J Urol; 1991 Feb; 145(2):279-83. PubMed ID: 1988718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography.
    Wahl RL; Hutchins GD; Buchsbaum DJ; Liebert M; Grossman HB; Fisher S
    Cancer; 1991 Mar; 67(6):1544-50. PubMed ID: 2001543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.
    Rege SD; Hoh CK; Glaspy JA; Aberle DR; Dahlbom M; Razavi MK; Phelps ME; Hawkins RA
    Cancer; 1993 Jul; 72(1):82-90. PubMed ID: 8389668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice.
    Yoshioka T; Takahashi H; Oikawa H; Maeda S; Ido T; Akaizawa T; Fukuda H; Kanamaru R
    J Nucl Med; 1997 May; 38(5):714-7. PubMed ID: 9170434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validity of positron emission tomography (PET) using 2-deoxy-2-[18F]fluoro-D-glucose (FDG) in patients with renal cell carcinoma (preliminary report)].
    Kawamura J; Hida S; Yoshida O; Yonekura Y; Senda M; Yamamoto K; Saji H; Fujita T; Konishi J
    Kaku Igaku; 1988 Oct; 25(10):1143-8. PubMed ID: 3265450
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.
    Yonekura Y; Benua RS; Brill AB; Som P; Yeh SD; Kemeny NE; Fowler JS; MacGregor RR; Stamm R; Christman DR; Wolf AP
    J Nucl Med; 1982 Dec; 23(12):1133-7. PubMed ID: 6982967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.
    Wahl RL; Cody RL; Hutchins GD; Mudgett EE
    Radiology; 1991 Jun; 179(3):765-70. PubMed ID: 2027989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
    Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
    Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging.
    Wang FL; Tan YY; Gu XM; Li TR; Lu GM; Liu G; Huo TL
    Chin Med J (Engl); 2016 Dec; 129(24):2926-2935. PubMed ID: 27958224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer detected by positron emission tomography with 18F-labelled deoxyglucose: method and first results.
    Bares R; Klever P; Hellwig D; Hauptmann S; Fass J; Hambuechen U; Zopp L; Mueller B; Buell U; Schumpelick V
    Nucl Med Commun; 1993 Jul; 14(7):596-601. PubMed ID: 8355920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
    Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
    Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes.
    Wahl RL; Kaminski MS; Ethier SP; Hutchins GD
    J Nucl Med; 1990 Nov; 31(11):1831-5. PubMed ID: 2230996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
    Gritters LS; Francis IR; Zasadny KR; Wahl RL
    J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
    Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
    Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET FDG studies of Wilms tumors.
    Shulkin BL; Chang E; Strouse PJ; Bloom DA; Hutchinson RJ
    J Pediatr Hematol Oncol; 1997; 19(4):334-8. PubMed ID: 9256833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study on the effectiveness of PET tumor images for cancer diagnosis].
    Yoshioka T; Takahashi H; Oikawa H; Kanamaru R
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):369-73. PubMed ID: 8109993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy.
    Sisson JC; Ackermann RJ; Meyer MA; Wahl RL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1090-4. PubMed ID: 8408458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.
    Wahl RL; Zasadny K; Helvie M; Hutchins GD; Weber B; Cody R
    J Clin Oncol; 1993 Nov; 11(11):2101-11. PubMed ID: 8229124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.